Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




David Pall, Founder of Pall Corporation, Dies at 90.

By Labmedica staff writers
Posted on 07 Oct 2004
Dr. More...
David B. Pall, a chemist who founded the Pall Corporation in 1946 to commercialize his invention of a novel metallic filtration material, died on September 21, 2004, at his home in Roslyn Estates (NY, USA). He was 90.

David Boris Pall was born in Thunder Bay, Ontario (Canada) in April 1914, the son of Russian immigrants. He received his Ph.D. in physical chemistry from McGill University (Montreal) in 1939. After that, he moved to New York (NY, USA), where he worked as a research chemist on the Manhattan Project, a secret program resulting in the development of the atomic bomb.

In 1944, Dr. Pall began working in his garage on a metallic filter that would be able to handle heavy pressure, high temperatures, and corrosive materials. He invented many different kinds of filters and received 181 U.S. patents on his designs. Some designs were for filters used aboard airplanes or on helicopter engines. After his first wife, Josephine, died of plastic anemia, he invented filters for purifying blood used in transfusions that have made the procedure much safer by protecting transfused patients from viruses and other harmful pathogens.

Dr. Pall established a company called the Micro Metallic Corp. in East Hills, NY (USA) to distribute his new designs. The name was later changed to the Pall Corporation, which grew into a global company and a world leader in filtration under his tenure. In 1990, Dr. Pall was awarded the U.S. National Medal of Technology, the nation's highest honor in technology. Dr. Pall retired as chairman of Pall Corporation in 1992.

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.